Results 31 to 40 of about 26,226 (199)

Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia

TH Open, 2020
Heparin-induced thrombocytopenia (HIT) is an immune adverse reaction to heparin that is associated with life-threatening thrombotic complications.
Michelangelo Sartori, Benilde Cosmi
doaj   +1 more source

Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review

Pharmacy, 2016
The purpose of this article is to report a case of fondaparinux outpatient utilization for anticoagulation in a patient with a past medical history of heparin-induced thrombocytopenia (HIT) and discuss the options and need for future anticoagulation ...
Amy Christopher
doaj   +1 more source

Safety and efficacy of thromboprophylaxis with fondaparinux in elderly acutely ill medical patients with renal impairment: a retrospective single center study

Italian Journal of Medicine, 2013
The majority of acutely ill medical patients are elderly with some degree of renal impairment. In this setting, venous thromboembolism (VTE) is one of the leading causes of morbidity and mortality and, to reduce this risk, a correct thromboprophylaxis is
Federico Silvestri, Samantha Pasca, Marco Zaramella, Antonella Labombarda, Andrea Barbi, Mauro Desideri, Paolo Guidi, Adolfo Rogato, Matteo Bergamo, Giovanni Barillari   +9 more
doaj   +1 more source

Application, tolerance and safety of fondaparinux therapy in a German hospital: a prospective single-centre experience. [PDF]

, 2012
INTRODUCTION The pentasaccharide fondaparinux is widely approved for prophylaxis and treatment of thromboembolic diseases and therapy of acute coronary syndrome. It is also used off-label in patients with acute, suspected or antecedent heparin-induced
Schindewolf, Marc, Marc Schindewolf, Hartmut Kroll, Marzi, Ingo, Julia Scheuermann, Boehncke, Wolf-Henning, Roland Kaufmann, Ludwig, Ralf J, Ludwig, Ralf J., Kroll, Hartmut, Wolf-Henning Boehncke, Ingo Marzi, Scheuermann, Julia, Edelgard Lindhoff-Last, Ralf J. Ludwig, Kaufmann, Roland, Lindhoff-Last, Edelgard   +16 more
core   +1 more source

Fondaparinux versus Enoxaparina no Tratamento de Pacientes Obesos com Síndrome Coronariana Aguda [PDF]

Arquivos Brasileiros de Cardiologia
Resumo Fundamento: O fondaparinux é um anticoagulante eficaz e seguro usado no tratamento de síndromes coronarianas agudas (SCAs). No entanto, devido à baixa representatividade de indivíduos obesos em ensaios clínicos, os efeitos de se aplicar os ...
Beatriz Rocha Darzé, Carolina Costa da Silva Souza, Queila Borges de Oliveira, João Victor Santos Pereira Ramos, Mateus S. Viana, Eduardo Sahade Darzé, Luiz Eduardo Fonteles Ritt   +6 more
doaj   +1 more source

Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region.

PLoS ONE, 2023
IntroductionLow Molecular Weight Heparins (LMWHs) and Fondaparinux have been widely used as anticoagulants. Mass prescription may lead to prescriptive inappropriateness, which causes Heparin-induced thrombocytopenia and other side effects.ObjectivesThe ...
Giaele Moretti, Bruna Vinci, Simona Zito, Alessia Caputo, Francesco Attanasio, Milena Vainieri   +5 more
doaj   +1 more source

Changes in ROTEM due to incubation with fondaparinux or enoxaparin.

, 2023
Changes in ROTEM due to incubation with fondaparinux or enoxaparin.
Frederik Müller (14419864), Marco Mannes (10193114), Amadeo Klitzing (14419867), David Alexander Christian Messerer (10307306), Christian Karl Braun (6919901), Markus Huber-Lang (64561), Kristina Nilsson Ekdahl (11327781), Bo Nilsson (54824), Frieder Scheibenberger (14419861), Anke Schultze (4543873), Doreen Tabea Spiegelburg (14419858)   +10 more
core   +1 more source

Fondaparinux and its derivatives

, 2018
Fondaparinux is a pentasaccharide and consists of the five saccharides by which heparin and low-molecular weight heparins bind to and potentiate antithrombin.
Michiel Coppens
core   +1 more source

Atrophic Papulosis: A Systematic Review of Pediatric Cases

Pediatric Dermatology, EarlyView.
ABSTRACT Background Atrophic papulosis is a rare occlusive vasculopathy that can present with isolated cutaneous disease or with systemic involvement. Pediatric cases are uncommon, and existing reports are heterogeneous, limiting understanding of disease patterns, timing of organ involvement, and outcomes.
Ou Jia Emilie Wang, Alennie Lopez, Renee Gabrielle Fajardo, Richard I. Crawford, Joseph M. Lam   +4 more
wiley   +1 more source

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa

Clinical and Applied Thrombosis/Hemostasis, 2020
Andexanet alfa is a recombinant factor Xa decoy protein, designed to reverse bleeding associated with oral anti-Xa agents. Andexanet alfa is also reported to neutralize the effects of heparin-related drugs.
Fakiha Siddiqui BDS, Alfonso Tafur MD, Emily Bontekoe BS, Omer Iqbal MD, Walter Jeske PhD, Siddharth Mehrotra, Debra Hoppensteadt PhD, Eduardo Ramacciotti MD, PhD, Jawed Fareed PhD   +8 more
doaj   +1 more source